Demographic, clinical and device profiles of 4466 patients implanted with a first implantable pulse generator (IPG) in a geographically diverse population von Sweidan, R., Ansabergs, J., Benezet, J. M., Padour, M., Lorgat, F., Urena, P., Pandurangi, U., West, T., Al Kandari, F.

Volltext

Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia von Schrier, Robert W, Gross, Peter, Gheorghiade, Mihai, Berl, Tomas, Verbalis, Joseph G, Czerwiec, Frank S, Orlandi, Cesare

Volltext

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention von Vaduganathan, Muthiah, MD, MPH, Harrington, Robert A., MD, Stone, Gregg W., MD, Deliargyris, Efthymios N., MD, Steg, Ph. Gabriel, MD, Gibson, C. Michael, MS, MD, Hamm, Christian W., MD, Price, Matthew J., MD, Menozzi, Alberto, MD, Prats, Jayne, PhD, Elkin, Steven, MS, Mahaffey, Kenneth W., MD, White, Harvey D., DSc, Bhatt, Deepak L., MD, MPH

Volltext